UBS Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-37,303
| Closed | -$1.24M | – | 9390 |
|
|
2024
Q3 | $1.24M | Buy |
37,303
+7,162
| +24% | +$239K | ﹤0.01% | 3411 |
|
|
2024
Q2 | $815K | Sell |
30,141
-8,973
| -23% | -$243K | ﹤0.01% | 3564 |
|
|
2024
Q1 | $845K | Buy |
39,114
+23,876
| +157% | +$516K | ﹤0.01% | 3670 |
|
|
2023
Q4 | $91.9K | Buy |
15,238
+6,952
| +84% | +$41.9K | ﹤0.01% | 5021 |
|
|
2023
Q3 | $46.1K | Sell |
8,286
-773
| -9% | -$4.3K | ﹤0.01% | 5207 |
|
|
2023
Q2 | $66.5K | Buy |
9,059
+8,531
| +1,616% | +$62.6K | ﹤0.01% | 5246 |
|
|
2023
Q1 | $2.12K | Sell |
528
-443
| -46% | -$1.78K | ﹤0.01% | 7475 |
|
|
2022
Q4 | $3.17K | Buy |
+971
| New | +$3.17K | ﹤0.01% | 8356 |
|
|
2022
Q3 | – | Sell |
-64
| Closed | – | – | 10568 |
|
|
2022
Q2 | $0 | Buy |
+64
| New | – | ﹤0.01% | 10521 |
|
|
2021
Q4 | – | Sell |
-1,430
| Closed | -$13K | – | 10066 |
|
|
2021
Q3 | $13K | Sell |
1,430
-1,759
| -55% | -$16K | ﹤0.01% | 6590 |
|
|
2021
Q2 | $29K | Buy |
3,189
+2,593
| +435% | +$23.6K | ﹤0.01% | 5914 |
|
|
2021
Q1 | $10K | Buy |
+596
| New | +$10K | ﹤0.01% | 6953 |
|